General Info
| Host: | Rat |
| Applications: | FC |
| Reactivity: | Mouse |
| Note: | FOR SCIENTIFIC EDUCATIONAL RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR OTHER MEDICAL APPLICATIONS. |
| Short Description: | Rat monoclonal antibody anti-CD16/32 is suitable for use in Flow Cytometry research applications. |
| Clonality: | Monoclonal |
| Clone ID: | 2.4G2 |
| Conjugation: | PE/Cyanine5 |
| Isotype: | IgG2bk |
| Formulation: | Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant. |
| Concentration: | 5 Mu L/Test |
| Storage Instruction: | Recommend storing between 2-8°C and protecting from prolonged exposure to light. Do not freeze this product. |
Information
| Gene Symbol: | Fcgr3 Fcgr2 |
| Gene ID: | NA 14130 |
| Uniprot ID: | FCGR3_MOUSE FCGR2_MOUSE |
Description
| Tissue Specificity | P08508 - NA P08101 - Widely expressed by cells of hemopoietic origin. The isoforms are differentially expressed. Isoform IIB1 is preferentially expressed by cells of the lymphoid lineage, isoform IIB2 by cells of the myeloid lineage, and isoform IIB3 is released by macrophages and is present in the serum. Isoform IIB1' is expressed in myeloid and lymphoid cell lines, in normal spleen cells, and in resting or LPS-activated B-cells but is not detected in mesenteric lymph node cells. |
| Alternative Antibody Names | Anti-Low Affinity Immunoglobulin Gamma Fc Region Receptor Iii antibody Anti-Igg Fc Receptor Iii antibody Anti-Fc-Gamma Riii antibody Anti-Fcriii antibody Anti-Cd Antigen Cd16 antibody Anti-Fcgr3 antibody Anti-Low Affinity Immunoglobulin Gamma Fc Region Receptor Ii antibody Anti-Fc Gamma Receptor Iib antibody Anti-Fc-Gamma Rii antibody Anti-Fc-Gamma-Riib antibody Anti-Fcrii antibody Anti-Igg Fc Receptor Ii Beta antibody Anti-Lymphocyte Antigen 17 antibody Anti-Ly-17 antibody Anti-Cd Antigen Cd32 antibody Anti-Fcgr2 antibody Anti-Fcgr2b antibody Anti-Ly-17 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance